HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

6 hedge funds and large institutions have $215K invested in Hepion Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$33.3K
2
+$27K
3
+$16K

Top Sellers

1
-$116K
2
-$14K
3
-$11K
4
CS
Credit Suisse
Switzerland
-$11K
5
Morgan Stanley
Morgan Stanley
New York
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$50K
2
$37K
3
$29K
4
$27K
5
$17K
6
$16K
7
$9K
8
$7K
9
$7K
10
$6K
11
$6K
12
$2K
13
$1K
14
$1K
15
–